# Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome

Study · id `cardio:ct-nct05183178` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05183178](<https://clinicaltrials.gov/study/NCT05183178>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05183178

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 17095 participants.

## Technical summary

Registry record NCT05183178. Randomized; no masking; primary purpose treatment. Start 2022-02-01 (actual); primary completion 2025-08-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 17095 participants (enrolled count; ClinicalTrials.gov record NCT05183178, source copy `cardio:ctgov-nct05183178-2026-07-08`, retrieved 2026-10-31)
- Started: 2022-02-01 (actual) (ClinicalTrials.gov record NCT05183178, source copy `cardio:ctgov-nct05183178-2026-07-08`, retrieved 2026-10-31)
- Primary completion: 2025-08-31 (actual) (ClinicalTrials.gov record NCT05183178, source copy `cardio:ctgov-nct05183178-2026-07-08`, retrieved 2026-10-31)
- Completion: 2025-08-31 (actual) (ClinicalTrials.gov record NCT05183178, source copy `cardio:ctgov-nct05183178-2026-07-08`, retrieved 2026-10-31)
- Countries: Sweden (ClinicalTrials.gov record NCT05183178, source copy `cardio:ctgov-nct05183178-2026-07-08`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05183178-2026-07-08`, retrieved 2026-10-31)

## The registry's words

- Brief title: Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome
- Acronym: SWITCH
- Condition: Acute Coronary Syndrome
- Intervention (Drug): Prasugrel 10 mg p.o
- Intervention (Drug): Ticagrelor 90 mg
- Lead sponsor: Vastra Gotaland Region
- Lead sponsor class: OTHER\_GOV
- Collaborator: Region Skane
- Collaborator class: OTHER
- Collaborator: Region Halland
- Collaborator class: OTHER
- Collaborator: Region Gävleborg
- Collaborator class: OTHER
- Collaborator: Region Örebro County
- Collaborator class: OTHER
- Collaborator: Region Västerbotten
- Collaborator class: OTHER\_GOV
- Collaborator: Jämtland County Council, Sweden
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry lists this organization as the lead sponsor: Vastra Gotaland Region (`cardio:org-vastra-gotaland-region`)
- Registry lists this organization as a collaborator: Region Skane (`cardio:org-region-skane`)
- Registry lists this organization as a collaborator: Region Halland (`cardio:org-region-halland`)
- Registry lists this organization as a collaborator: Region Örebro County (`cardio:org-region-orebro-county`)

## Provenance

Content hash: b5d8babc1f7528cac4ff7307d4846446adfa2a7f7df150fb44de8fc68ffd9ad3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
